课题基金 / 基金详情

POLYCHELATING AGENT INCORPORATION LIPOSOMES & MICELLES

POLYCHELATING AGENT INCORPORATION LIPOSOMES & MICELLES
多螯合剂掺入脂质体
批准号:
6016557
负责人:
John W Babich
金额:
$9.84万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2000-02-29

项目摘要

项目成果

John W Babich的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A novel polymeric probe capable of chelating multiple metal atoms (In, Gd) and suitable for the incorporation into liposomes and micelles will be synthesized and tested in vitro. A new molecule represents low-molecular- weight DTPA-polylysine linked via its N-terminus to a lipid anchor, NGPE-PE (DTPA-PLL-PE). In a preliminary experiment, we demonstrated here that liposomes containing 3 mole % of new membrane- bound polychelator and loaded with Gd possess enhanced relaxivity for water protons when compared with liposomes loaded with Gd via known membranotropic DTPA-SA and DTPA-PE. Liposomes will be prepared with variable contents of DTPA-PLL-PE and polyethylene glycol-PE (PEG-PE) and optimized in terms of their relaxivity and stability towards blood plasma. PED-PE-based micelles will be prepared containing variable quantities of DTPA-PLL-PE will be prepared. Their relaxivity and stability will be studied upon loading with Gadolinium. PROPOSED COMMERCIAL APPLICATIONS: Currently there are no vascular imaging agents marketed for Magnetic Resonance Imaging. There are 8 million cases of coronary artery disease per year of which there are one million scans estimated for this population. A MRI angiography contrast agent would have a large potential market in the USA alone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Radiolabeled FASN Inhibitors for PET Imaging
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma